Shilpa Medicare Ltd updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana

Shilpa Medicare Limited, Unit 4, Jadcherla, Telangana, India had Europe GMP inspection by AGES, Austria from 22 January, 2024 until 26 January, 2024. This inspection has concluded with two minor observations.

The previous EU - GMP inspection for this facility was in January 2020.

This Unit of Shilpa Medicare is engaged in the manufacture, testing and distribution of sterile Injections and non-sterile tablets and Capsule finished dosage forms in the US, Europe and rest of the world markets.

The Company intends to respond to the two minor observations within the stipulated time and is committed for the satisfactory resolution of the inspectional observations and sustained cGMP compliance.

Shares of Shilpa Medicare Limited was last trading in BSE at Rs. 331.00 as compared to the previous close of Rs. 320.80. The total number of shares traded during the day was 5988 in over 396 trades.

The stock hit an intraday high of Rs. 333.20 and intraday low of 318.85. The net turnover during the day was Rs. 1955154.00.

Source : Equity Bulls

Keywords

ShilpaMedicare INE790G01031 Europe GMPInspection Unit4 Jadcherla Telangana